SCHEDULE 13G/A//SEC Filing
AN2 Therapeutics, Inc. SCHEDULE 13G/A
Accession 0000950170-25-021346
CIK 0001839947other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:44 PM ET
Size
113.5 KB
Accession
0000950170-25-021346
Documents
Issuer
TCG Crossover GP I, LLC
CIK 0001839947
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001839947
Filing Metadata
- Form type
- SCHEDULE 13G/A
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 4:44 PM ET
- Size
- 113.5 KB